Regulation of expression of MSG1 melanocyte-specific nuclear protein in human melanocytes and melanoma cells

Experimental Cell Research

Volumn 242, Issue 2, 1998, Pages 478-486

  Li, Huchun ^a   Ahmed, Nazim U ^b   Fenner, Martin H ^a   Ueda, Masato ^b   Isselbacher, Kurt J ^a   Shioda, Toshi ^a  

^a MASSACHUSETTS GENERAL HOSPITAL CANCER CENTER   (United States)

^b KOBE UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Differentiation; Endothelin 1; FGF 2 fibroblast growth factor; Phorbol ester; Pigmentation

Indexed keywords

NUCLEAR PROTEIN;

ARTICLE; GENE EXPRESSION; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; MELANOCYTE; MELANOMA CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PROCESSING; RNA TRANSCRIPTION; RNA TRANSLATION;

EID: 0032146102     PISSN: 00144827     EISSN: None     Source Type: Journal    
DOI: 10.1006/excr.1998.4123     Document Type: Article

References (27)

1. Shioda T., Fenner M. H., Isselbacher K. J. msg1, Proc. Natl. Acad. Sci. USA. 93:1996;12298-12303.
2. Shioda T., Fenner M. H., Isselbacher K. J. MSG1 and its related protein MRG1 share a transcription activating domain. Gene. 204:1997;235-241.
3. Dunwoodie S. L., Rodriguez T., Beddington S. P. Msg1Mrg1, Mech. Dev. 72:1998;27-40.
4. Halaban R., Langdon R., Birchall N., Cuono C., Baird A., Scott G., Moellmann G., McGuire J. Basic fibroblast growth factor from human keratinocytes is a natural mitogen for melanocytes. J. Cell Biol. 107:1988;1611-1619.
5. Yada Y., Higuchi K., Imokawa G. Effects of endothelins on signal transduction and proliferation in human melanocytes. J. Biol. Chem. 266:1991;18352-18357.
6. Imokawa G., Yada Y., Miyagishi M. Endothelins secreted from human keratinocytes are intrinsic mitogens for human melanocytes. J. Biol. Chem. 267:1992;24675-24680.
7. Imokawa G., Miyagishi M., Yada Y. Endothelin-1 as a new melanogen: Coordinated expression of its gene and the tyrosinase gene in UVB-exposed human epidermis. J. Invest. Dermatol. 105:1995;32-37.
8. Swope V. B., Medrano E. E., Smalara D., Abdel-Malek Z. A. Long-term proliferation of human melanocytes is supported by the physiologic mitogens α-melanotropin, endothelin-1, and basic fibroblast growth factor. Exp. Cell Res. 217:1995;453-459.
9. Imokawa G., Kobayashi T., Miyagishi M., Higashi K., Yada Y. The role of endothelin-1 in epidermal hyperpigmentation and signaling mechanisms of mitogenesis and melanogenesis. Pigm. Cell Res. 10:1997;218-228.
10. Byers H. R., Etoh T., Doherty J. R., Sober A. J., Mihm M. C. Jr. Cell migration and actin organization in cultured human primary, recurrent cutaneous, and metastatic melanoma. Am. J. Pathol. 139:1991;423-435.
11. Fidler I. J., Gruys E., Cifone M. A., Barnes Z., Bucana C. Demonstration of multiple phenotypic diversity in a murine melanoma of recent origin. J. Natl. Cancer Inst. 67:1981;947-956.
12. Harlow E., Lane D. Antibodies: A laboratory manual. 1988;Cold Spring Harbor Laboratory Press, Cold Spring Harbor.
13. Herlyn M., Mancianti M. L., Jambrosic J., Bolen J. B., Koprowski H. Regulatory factors that determine growth and phenotype of normal human melanocytes. Exp. Cell Res. 179:1988;322-331.
14. Halaban R. Growth factors and melanomas. Semin. Oncol. 23:1996;673-681.
15. Eisinger M., Marko O. Selective proliferation of normal human melanocytesin vitro. Proc. Natl. Acad. Sci. USA. 79:1982;2018-2022.
16. Kerbel R. S. Growth dominance of the metastatic cancer cell: Cellular and molecular aspects. Adv. Cancer Res. 55:1990;87-132.
17. Herlyn M., Kath R., Williams N., Valyi-Nagy I., Rodeck U. Growth-regulatory factors for normal, premalignant, and malignant human cellsin vitro. Adv. Cancer Res. 54:1990;213-234.
18. Bennett D. C. Colour genes, oncogenes and melanocyte differentiation. J. Cell Sci. 98:1991;135-139.
19. Bennett D. C. Genetics, development, and malignancy of melanocytes. Int. Rev. Cytol. 146:1993;191-260.
20. Soballe P. W., Herlyn M. Cellular pathways leading to melanoma differentiation: Therapeutic implications. Melanoma Res. 4:1994;213-223.
21. Zeng Y.-X., Somasundaram K., El-Deiry W. S. AP2 inhibits cancer cell growth and activates p21WAF1/CIP1 expression. Nat. Genet. 15:1997;78-82.
22. Esposito F., Cuccovillo F., Vanoni M., Cimino F., Anderson C. W., Appella E., Russo T. Redox-mediated regulation of p21(waf1/cip1) expression involves a post-transcriptional mechanism and activation of the mitogen-activated protein kinase pathway. Eur. J. Biochem. 245:1997;730-737.
23. Halaban R., Rubin J. S., Funasaka Y., Cobb M., Boulton T., Faletto D., Rosen E., Chan A., Yoko K., White W., Cook C., Moellmann G. Met and hepatocyte growth factor/scatter factor signal transduction in normal melanocytes and melanoma cells. Oncogene. 7:1992;2195-2206.
24. Ueda M., Funasaka Y., Ichibashi M., Mishima Y. Stable and strong expression of basic fibroblast growth factor in naevus cell naevus contrasts with aberrant expression in melanoma. Br. J. Dermatol. 130:1994;320-324.
25. Ahmed N. U., Ueda M., Ito A., Ohashi A., Funasaka Y., Ichihashi M. Expression of fibroblast growth factor receptors in naevus-cell naevus and malignant melanoma. Melanoma Res. 7:1997;299-305.
26. Dotto G. P., Moellmann G., Ghosh S., Edwards M., Halaban R. Transformation of murine melanocytes by basic fibroblast growth factor cDNA and oncogenes and selective suppression of the transformed phenotype in a reconstituted cutaneous environment. J. Cell Biol. 109:1989;3115-3128.
27. Becker D., Lee P. L., Rodeck U., Herlyn M. Inhibition of the fibroblast growth factor receptor 1 (FGFR-1) gene in human melanocytes and malignant melanomas leads to inhibition of proliferation and signs indicative of differentiation. Oncogene. 7:1992;2303-2313.